Novan Announces Publication of Positive Results from Pivotal

– The B-SIMPLE4 pivotal Phase 3 clinical study of berdazimer gel, 10.3% (SB206) is the largest interventional trial of molluscum contagiosum ("molluscum")...

Related Keywords

United States , United Kingdom , Adelaide , South Australia , Australia , London , City Of , American , Stephanw Stripling , Paula Brown Stafford , Pediatr Dermatol , Prnewswire Novan Inc , Drug Administration , Coastal Pediatric Research , Exchange Commission , Exchange Commission On Form , Novan Inc , Company Or Novan Nasdaq , American Academy Of Dermatology , Pediatric Dermatology At Mcgovern School Of Medicine , Elsevier , Adelaide Herbert , Pediatric Dermatology , Mcgovern School , Memorial Hermann , Molluscum Patients , Co Medical Director , New Drug Application , Chief Executive Officer , Private Securities Litigation Reform Act , Accessed July , Treasure Island , Statpearls Publishing , Pharmacy Benefits Claims , Syneos Insights Suite , Onovan , Nc ,